Smith Thornton Advisors LLC Bristol Myers Squibb CO Transaction History
Smith Thornton Advisors LLC
- $158 Billion
- Q4 2024
A detailed history of Smith Thornton Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 3,881 shares of BMY stock, worth $216,676. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,881
Previous 3,911
0.77%
Holding current value
$216,676
Previous $202 Million
8.48%
% of portfolio
0.14%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...